Fresenius Kabi Introduces Pralatrexate Injection for the Treatment of Relapsed or Refractory Peripheral T-cell Lymphoma
LAKE ZURICH, Ill.--(BUSINESS WIRE)--Dec 8, 2022--
Source: wsiltv.com
Stay updated with breaking news from Avoid Pralatrexate. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
LAKE ZURICH, Ill.--(BUSINESS WIRE)--Dec 8, 2022--